Patents Assigned to VETERINÆRINSTITUTTET
  • Salmon gill poxvirus
    Patent number: 10640752
    Abstract: The present document is directed to a new poxvirus infecting salmon. The present document further discloses the genomic sequence of this double-stranded DNA virus and the use of this sequence information for detection, diagnosis and/or vaccine development for the virus.
    Type: Grant
    Filed: December 22, 2015
    Date of Patent: May 5, 2020
    Assignee: VETERINÆRINSTITUTTET
    Inventors: Mona Cecilie Gjessing, Torstein Tengs
  • Outer membrane vesicles and uses thereof
    Patent number: 10314902
    Abstract: The disclosure relates to outer membrane vesicles from Francisella and Piscirickettsia, and their use in vaccine compositions. In particular, the present disclosure relates to compositions and methods useful in inducing protective immunity against francisellosis or salmon rickettsial septicaemia (SRS) in fish.
    Type: Grant
    Filed: May 23, 2018
    Date of Patent: June 11, 2019
    Assignees: UNIVERSITY OF OSLO, VETERINÆRINSTITUTTET, NMBU VETERINÆRHØ GSKOLEN
    Inventors: Hanne Winther-Larsen, Espen Brudal, Duncan Colquhoun
  • Outer membrane vesicles and uses thereof
    Patent number: 9993541
    Abstract: The disclosure relates to outer membrane vesicles from Francisella and Piscirickettsia, and their use in vaccine compositions. In particular, the present disclosure relates to compositions and methods useful in inducing protective immunity against francisellosis or salmon rickettsial septicaemia (SRS) in fish.
    Type: Grant
    Filed: November 13, 2014
    Date of Patent: June 12, 2018
    Assignees: UNIVERSITY OF OSLO, NIMBU VETERINÆRHØGSKOLEN, VETERINÆRINSTITUTTET
    Inventors: Hanne Winther-Larsen, Espen Brudal, Duncan Colquhoun
  • Fusion proteins for the treatment of allergic diseases
    Patent number: 9802999
    Abstract: The present invention relates to a fusion protein comprising a first peptide and a second peptide linked together with a linker, wherein the first peptide is an allergen and the second peptide is a targeting unit and the targeting unit is a FGL-2 C-terminal peptide according to SEQ ID no 1. Provided herein are also uses of said fusion protein as a vaccine for treating allergy, such as shrimp, peanut or mite allergy, as well as a vaccine composition and methods for producing such fusion proteins.
    Type: Grant
    Filed: October 30, 2013
    Date of Patent: October 31, 2017
    Assignee: VETERINAERINSTITUTTET
    Inventors: Maaike Maria Barbara Wilhelmina Dooper, Bjarne Bogen, Heidi Ragnhild Myrset
  • A METHOD FOR TRICHOTHECENE DETOXIFICATION
    Publication number: 20170071235
    Abstract: The present document is directed to detoxification of trichothecenes using a method involving trichothecene epoxide ring opening. In particular, the present document discloses the detoxification of a trichothecene by reaction with a thiol containing compound under conditions where the pH is equal to or higher than one pH unit less than the pKa of a thiol group of the thiol containing compound.
    Type: Application
    Filed: May 6, 2015
    Publication date: March 16, 2017
    Applicant: VETERINÆRINSTITUTTET
    Inventors: Ana STANIC, Silvio UHLIG, Christopher Owen MILES
  • Fusion proteins for the treatment of allergic diseases
    Patent number: 9005630
    Abstract: The present invention relates to a fusion protein comprising a first peptide and a second peptide linked together with a linker, wherein the first peptide is an allergen and the second peptide is a targeting unit and the second targeting unit peptide is a FGL-2 C-terminal peptide according to SEQ ID no 1. Provided herein are also uses of said fusion protein as a vaccine for treating shrimp allergy, as well as a vaccine composition and methods of its production.
    Type: Grant
    Filed: November 1, 2012
    Date of Patent: April 14, 2015
    Assignee: Veterinaerinstituttet
    Inventors: Maaike Maria Barbara Wilhelmina Dooper, Bjarne Bogen, Heidi Ragnhild Myrset
  • FUSION PROTEINS FOR THE TREATMENT OF ALLERGIC DISEASES
    Publication number: 20140120123
    Abstract: The present invention relates to a fusion protein comprising a first peptide and a second peptide linked together with a linker, wherein the first peptide is an allergen and the second peptide is a targeting unit and the second targeting unit peptide is a FGL-2 C-terminal peptide according to SEQ ID no 1. Provided herein are also uses of said fusion protein as a vaccine for treating shrimp allergy, as well as a vaccine composition and methods of its production.
    Type: Application
    Filed: November 1, 2012
    Publication date: May 1, 2014
    Applicant: Veterinaerinstituttet
    Inventors: Maaike Maria Barbara Wilhelmina Dooper, Bjarne Bogen, Heidi Ragnhild Myrset